Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Thiel (Zurich, Switzerland), F. Lettau (Zurich, Switzerland), S. Haile (Zurich, Switzerland), P. Rejmer (Zurich, Switzerland), E. Schwarz (Zurich, Switzerland), A. Stöberl (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), C. Rossi (Zurich, Switzerland), A. Becker (Zurich, Switzerland), A. Boss (Zurich, Switzerland), J. Stradling (Oxford, United Kingdom), M. Kohler (Zurich, Switzerland). The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial.. 3289

Member's Comments

No comment yet.

Related content which might interest you: The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Impact of hypertension on cerebral microvascular structure in obstructive sleep apnoea patients:a diffusion magnetic-resonance imaging study. Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude Year: 2019 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Increased arterial stiffness in patients with obstructive sleep apnea: clinical implication Source: Sleep and Breathing Conference 2021 Year: 2021 Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020 Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnoea syndrome Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study Source: Eur Respir J 2001; 18: 630-634 Year: 2001 Impact of a short rehabilitation program on fat visceral and blood pressure on patients with obstructive sleep apnea syndrome (OSAS). A randomized controlled study Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training Year: 2007 Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003 Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007